News Digest / Ticker: ALC

Ticker: ALC

03:32am, Tuesday, Jul 01, 2025

UBS Downgrades Galderma to Neutral as Aesthetics Market Faces Headwinds: What Investors Need to Know

UBS has downgraded Galderma Group AG (SIX: GALD) from "buy" to "neutral," citing valuation concerns and a cooling aesthetics market. The 12-month price target is revised to CHF120. Traders should brace for potential slowing growth in key product segments.

04:53am, Wednesday, Aug 21, 2024

Alcon's Earnings Miss Sparks Cautious Trading While 2024 Outlook Remains Optimistic

08:27am, Tuesday, Aug 20, 2024

3 Healthcare Sector Stocks Worth Watching in September